港股異動丨港股市場深圳股表現亮眼 深圳喜迎中央重磅“大禮包”
格隆匯10月12日丨港股市場深圳股表現亮眼,深圳控股漲超7%,深圳國際漲逾6%,佳兆業集團漲5.46%。中共中央辦公廳、國務院辦公廳昨日印發《深圳建設中國特色社會主義先行示範區綜合改革試點實施方案(2020-2025年)》。目標到2022年,各方面制度建設取得重要進展,形成一批可複製可推廣的重大制度成果,試點取得階段性成效。2025年,重要領域和關鍵環節改革取得標誌性成果,基本完成試點改革任務,為全國制度建設作出重要示範。深圳經濟特區建立40週年慶祝大會將於14日上午在廣東省深圳市隆重舉行。中共中央總書記、國家主席、中央軍委主席習近平將出席大會並發表重要講話。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.